Work

Abstract OT1-05-02: A phase II study to evaluate the efficacy, safety and pharmacokinetics of DHP107 (Liporaxel®, oral paclitaxel) compared to IV paclitaxel in patients with recurrent or metastatic breast cancer: OPERA (NCT03326102)

Year: 2020

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs19-ot1-05-02

Authors: Timothy J Pluard, Priyanka Sharma, Michelle E. Melisko, Neelima Vidula, David E Weng, Jane D Skelton, Koung Eun Yoon, Hyun Ju Cho, Hope S Rugo

Institutions: Saint Luke's Hospital, University of Kansas, The University of Kansas Cancer Center, University of California, San Francisco, Massachusetts General Hospital, Anne Arundel Medical Center, Boca Raton Regional Hospital, Dae Hwa Pharm (South Korea)

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3006120160

Cites:

Cited by: 3

Related to: 10